How has been the historical performance of Roselabs Finance?

Answer:The historical performance of Roselabs Finance shows a gradual increase in net sales, with figures rising from 0.00 Cr in Mar'23 to 0.71 Cr in Mar'25, although it decreased from 1.14 Cr in Mar'24. The total operating income followed a similar trend, reaching 0.71 Cr in Mar'25 after peaking at 1.14 Cr in Mar'24. However, the company has consistently reported negative operating profits, with an operating profit (PBDIT) of -0.29 Cr in Mar'25, which is an improvement from -0.54 Cr in Mar'23 but still reflects ongoing challenges. The profit before tax also remained negative at -0.29 Cr in Mar'25, down from -0.13 Cr in Mar'24, while the profit after tax was -0.29 Cr in Mar'25, indicating a decline from -0.13 Cr in the previous year. The earnings per share (EPS) mirrored this trend, showing -0.29 in Mar'25 compared to -0.13 in Mar'24. The company's operating profit margin and PAT margin were both negative, at -43.66% and -40.85% respectively in Mar'25, highlighting the financial difficulties faced by Roselabs Finance.

Breakdown:
Roselabs Finance's financial performance has been characterized by fluctuating revenues and persistent losses over the years. The net sales have shown a slight increase, with a notable rise to 0.71 Cr in Mar'25 from 0.00 Cr in the previous years, though it fell from 1.14 Cr in Mar'24. Despite this increase in sales, the company has struggled with high expenditures, leading to negative operating profits, which were -0.29 Cr in Mar'25. This trend of losses continued with profit before tax and profit after tax both reported at -0.29 Cr for the same period. The earnings per share also reflected these losses, standing at -0.29 in Mar'25. Overall, while there has been some growth in sales, the company's profitability remains a significant concern, as indicated by the negative margins and ongoing financial challenges.